Carbapenem-resistant Enterobacteriaceae at a low prevalence tertiary care center: Patient-level risk factors and implications for an infection prevention strategy

Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
Author(s): Michelle Doll, Nadia Masroor, Yvette Major, Michele Fleming, Christopher Doern, Kaila Cooper, Michael Stevens, Gonzalo Bearman
Limited treatment options and a growing global threat from carbapenem-resistant Enterobacteriaceae (CRE) infections illustrate the importance of understanding the epidemiology of CRE. Using a retrospective chart review and point prevalence testing demonstrated specific patient risk factors for CRE-positive clinical cultures in a tertiary medical center with a low CRE prevalence.



http://ift.tt/2iiQUNX